Advertisement

iStent inject in phakic open angle glaucoma

  • Matthias K. J. Klamann
  • Johannes Gonnermann
  • Milena Pahlitzsch
  • Anna-Karina B. Maier
  • Antonia M. Joussen
  • Necip Torun
  • Eckart Bertelmann
Glaucoma

Abstract

Background

The effectiveness and complication profile of the iStent inject implantation among different open angle glaucoma subgroups were analyzed.

Methods

In this retrospective cohort outcome study, 35 consecutive patients suffering from glaucoma (primary open angle glaucoma (POAG) N = 17, pseudoexfoliation glaucoma (PEX) N = 15, and pigmentary glaucoma (PG) N = 3) were treated with the iStent inject. The intraocular pressure (IOP) and the number of antiglaucoma medications before and after surgery were evaluated.

Results

In POAG, the mean IOP at 6 months measured 14.19 ± 1.38 mmHg with an average decrease of 33 % from preoperative IOP (p < 0.001), and 15.33 ± 1.07 mmHg with an average decrease of 35 % in PEX (p < 0.001), respectively. The number of antiglaucoma medications significantly decreased from 2.19 ± 0.91 to 0.88 ± 0.62 in POAG (p < 0.001) and from 2.33 ± 1.23 to 1.04 ± 0.30 in PEX (p < 0.001) after 6 months. In PG, IOP before surgery was 28.31 ± 3.21 mmHg and the number of antiglaucoma medications was 3.66 ± 0.57. One day after surgery, IOP decreased significantly to 12.33 mmHg ± 4.93 (p < 0.001). Within four weeks after surgery, IOP was raised above 30 mmHg in every patient. To exclude a steroid response, topical steroids were stopped, but IOP did not decrease. To exclude blockage, Nd:YAG – laser treatment of the visible opening of the iStents was performed. Since the IOP stayed high and escalation of antiglaucoma medication was insufficient to control IOP, trabeculectomy was performed.

Conclusions

In conclusion, implantation of the iStent inject has the ability to lower the postoperative IOP significantly in POAG and PEX after a short follow-up of 6 months with a favorable risk profile. However, limitation of this surgical procedure in phakic PG may exist and need to be investigated in further studies.

Keywords

Pseudoexfoliation glaucoma Pigmentary glaucoma Primary open angle glaucoma Micro-invasive glaucoma surgery (MIGS) iStent inject 

Notes

Conflict of interest statement

All authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers’ bureaus, memberships, employment, consultancies, stock ownership, or other equity interest, and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, and knowledge or beliefs) in the subject matter or materials discussed in this manuscript.

References

  1. 1.
    Tezel G, Kass MA, Kolker AE, Wax MB (1996) Comparative optic disc analysis in normal pressure glaucoma, primary open-angle glaucoma, and ocular hypertension. Ophthalmology 103(12):2105–2113CrossRefPubMedGoogle Scholar
  2. 2.
    Cvenkel B, Kontestabile AS (2011) Correlation between nerve fibre layer thickness measured with spectral domain OCT and visual field in patients with different stages of glaucoma. Graefes Arch Clin Exp Ophthalmol 249(4):575–584CrossRefPubMedGoogle Scholar
  3. 3.
    Ritch R (1994) Exfoliation syndrome. The most common identifiable cause of open-angle glaucoma. J Glaucoma 3(2):176–178PubMedGoogle Scholar
  4. 4.
    Niyadurupola N, Broadway DC (2008) Pigment dispersion syndrome and pigmentary glaucoma–a major review. Clin Exp Ophthalmol 36(9):868–882CrossRefGoogle Scholar
  5. 5.
    Le K, Saheb H (2014) iStent trabecular micro-bypass stent for open-angle glaucoma. Clin Ophthalmol 8(9):1937–1945PubMedCentralPubMedGoogle Scholar
  6. 6.
    Voskanyan L, García-Feijoó J, Belda JI, Fea A, Jünemann A, Baudouin C, Synergy Study Group (2014) Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial. Adv Ther 31(2):189–201CrossRefPubMedCentralPubMedGoogle Scholar
  7. 7.
    Fea AM, Belda JI, Rękas M, Jünemann A, Chang L, Pablo L, Voskanyan L, Katz LJ (2014) Prospective unmasked randomized evaluation of the iStent inject(®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol 8(5):875–882PubMedCentralPubMedGoogle Scholar
  8. 8.
    Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE, for the US iStent Study Group (2011) Randomized evaluation of the trabecular microbypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118(3):459–467CrossRefPubMedGoogle Scholar
  9. 9.
    Fea AM (2010) Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma. J Cataract Refract Surg 36(3):407–412CrossRefPubMedGoogle Scholar
  10. 10.
    Craven ER, Katz LJ, Wells JM, Giamporcaro JE, for the iStent Study Group (2012) Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg 38(8):1339–1345CrossRefPubMedGoogle Scholar
  11. 11.
    Luebke J, Boehringer D, Neuburger M, Anton A, Wecker T, Cakir B, Reinhard T, Jordan JF (2015) Refractive and visual outcomes after combined cataract and trabectome surgery: a report on the possible influences of combining cataract and trabectome surgery on refractive and visual outcomes. Graefes Arch Clin Exp Ophthalmol 253(3):419–423CrossRefPubMedGoogle Scholar
  12. 12.
    Jordan JF, Wecker T, van Oterendorp C, Anton A, Reinhard T, Boehringer D, Neuburger M (2013) Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol 251(12):2753–2760CrossRefPubMedCentralPubMedGoogle Scholar
  13. 13.
    Klamann MK, Gonnermann J, Maier AK, Ruokonen PC, Torun N, Joussen AM, Bertelmann E (2013) Combined clear cornea phacoemulsification in the treatment of pseudoexfoliative glaucoma associated with cataract: significance of trabecular aspiration and ab interno trabeculectomy. Graefes Arch Clin Exp Ophthalmol 251(9):2195–2199CrossRefPubMedGoogle Scholar
  14. 14.
    Ting JL, Damji KF, Stiles MC, Trabectome Study Group (2012) Ab internotrabeculectomy: outcomes in exfoliation versus primary open-angle glaucoma. J Cataract Refract Surg 38(2):315–323CrossRefPubMedGoogle Scholar
  15. 15.
    Belovay GW, Nagi A, Chan BJ, Rateb M, Ahmed II (2012) Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg 38(11):1911–1917CrossRefPubMedGoogle Scholar
  16. 16.
    Arriola-Villalobos P, Martínez-de-la-Casa JM, Díaz-Valle D, García-Vidal SE, Fernández-Pérez C, García-Sánchez J, García-Feijoó J (2013) Mid-term evaluation of the new Glaukos iStent with phacoemulsification in coexistent open-angle glaucoma or ocular hypertension and cataract. Br J Ophthalmol 97(10):1250–1255CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Matthias K. J. Klamann
    • 1
  • Johannes Gonnermann
    • 1
  • Milena Pahlitzsch
    • 1
  • Anna-Karina B. Maier
    • 1
  • Antonia M. Joussen
    • 1
  • Necip Torun
    • 1
  • Eckart Bertelmann
    • 1
  1. 1.Department of OphthalmologyCharité - Universitätsmedizin BerlinBerlinGermany

Personalised recommendations